| Year |
Citation |
Score |
| 2021 |
Bertera S, Knoll MF, Knoll C, Hara H, Kimbrel EA, Kouris NA, Lanza R, Philips BE, Garciafigueroa Y, Giannoukakis N, Cooper DKC, Trucco M, Bottino R. Human Hemangioblast-Derived Mesenchymal Stem Cells Promote Islet Engraftment in a Minimal Islet Mass Transplantation Model in Mice. Frontiers in Medicine. 8: 660877. PMID 33937296 DOI: 10.3389/fmed.2021.660877 |
0.422 |
|
| 2020 |
Kimbrel EA, Lanza R. Next-generation stem cells - ushering in a new era of cell-based therapies. Nature Reviews. Drug Discovery. 19: 463-479. PMID 32612263 DOI: 10.1038/S41573-020-0064-X |
0.574 |
|
| 2019 |
Lanza R, Russell DW, Nagy A. Engineering universal cells that evade immune detection. Nature Reviews. Immunology. PMID 31417198 DOI: 10.1038/S41577-019-0200-1 |
0.419 |
|
| 2017 |
Qin Y, Chan AM, Chang YL, Matynia A, Kouris NA, Kimbrel EA, Ashki N, Parikh S, Gorin MB, Lanza R, Levinson RD, Gordon LK. Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Decrease the Development of Severe Experimental Autoimmune Uveitis in B10.RIII Mice. Ocular Immunology and Inflammation. 1-9. PMID 28914568 DOI: 10.1080/09273948.2017.1343356 |
0.544 |
|
| 2017 |
Wang JD, An Y, Zhang JS, Wan XH, Zhang W, Lanza R, Lu SJ, Jonas JB, Xu L. Retinal vascular injuries and intravitreal human embryonic stem cell-derived haemangioblasts. Acta Ophthalmologica. PMID 28636206 DOI: 10.1111/Aos.13477 |
0.472 |
|
| 2016 |
Kimbrel EA, Lanza R. Pluripotent stem cells: the last 10 years. Regenerative Medicine. 11: 831-847. PMID 27908220 DOI: 10.2217/Rme-2016-0117 |
0.499 |
|
| 2016 |
Barnea-Cramer AO, Wang W, Lu SJ, Singh MS, Luo C, Huo H, McClements ME, Barnard AR, MacLaren RE, Lanza R. Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice. Scientific Reports. 6: 29784. PMID 27405580 DOI: 10.1038/Srep29784 |
0.517 |
|
| 2015 |
McCabe KL, Kunzevitzky NJ, Chiswell BP, Xia X, Goldberg JL, Lanza R. Efficient Generation of Human Embryonic Stem Cell-Derived Corneal Endothelial Cells by Directed Differentiation. Plos One. 10: e0145266. PMID 26689688 DOI: 10.1371/Journal.Pone.0145266 |
0.568 |
|
| 2015 |
Thiel A, Yavanian G, Nastke MD, Morales P, Kouris NA, Kimbrel EA, Lanza R. Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis. Scientific Reports. 5: 17685. PMID 26628350 DOI: 10.1038/Srep17685 |
0.502 |
|
| 2015 |
Kimbrel EA, Lanza R. Current status of pluripotent stem cells: moving the first therapies to the clinic. Nature Reviews. Drug Discovery. 14: 681-92. PMID 26391880 DOI: 10.1038/Nrd4738 |
0.493 |
|
| 2015 |
Ferrer L, Kimbrel EA, Lam A, Falk EB, Zewe C, Juopperi T, Lanza R, Hoffman A. Treatment of perianal fistulas with human embryonic stem cell-derived MSCs: a canine model of human fistulizing Crohn's disease. Regenerative Medicine. PMID 26387424 DOI: 10.2217/Rme.15.69 |
0.483 |
|
| 2015 |
Schwartz SD, Anglade E, Lanza R. Stem cells in age-related macular degeneration and Stargardt's macular dystrophy - Authors' reply. Lancet (London, England). 386: 30. PMID 26169867 DOI: 10.1016/S0140-6736(15)61203-X |
0.447 |
|
| 2015 |
Song WK, Park KM, Kim HJ, Lee JH, Choi J, Chong SY, Shim SH, Del Priore LV, Lanza R. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in asian patients. Stem Cell Reports. 4: 860-72. PMID 25937371 DOI: 10.1016/J.Stemcr.2015.04.005 |
0.557 |
|
| 2015 |
Kimbrel EA, Lanza R. Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies. Regenerative Medicine. 10: 99-102. PMID 25835474 DOI: 10.2217/Rme.14.89 |
0.509 |
|
| 2015 |
Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, ... ... Lanza R, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet (London, England). 385: 509-16. PMID 25458728 DOI: 10.1016/S0140-6736(14)61376-3 |
0.471 |
|
| 2014 |
Thon JN, Mazutis L, Wu S, Sylman JL, Ehrlicher A, Machlus KR, Feng Q, Lu S, Lanza R, Neeves KB, Weitz DA, Italiano JE. Platelet bioreactor-on-a-chip. Blood. 124: 1857-67. PMID 25606631 DOI: 10.1182/Blood-2014-05-574913 |
0.315 |
|
| 2014 |
Feng Q, Shabrani N, Thon JN, Huo H, Thiel A, Machlus KR, Kim K, Brooks J, Li F, Luo C, Kimbrel EA, Wang J, Kim KS, Italiano J, Cho J, ... ... Lanza R, et al. Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Reports. 3: 817-31. PMID 25418726 DOI: 10.1016/J.Stemcr.2014.09.010 |
0.376 |
|
| 2014 |
Wang X, Kimbrel EA, Ijichi K, Paul D, Lazorchak AS, Chu J, Kouris NA, Yavanian GJ, Lu SJ, Pachter JS, Crocker SJ, Lanza R, Xu RH. Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis. Stem Cell Reports. 3: 115-30. PMID 25068126 DOI: 10.1016/J.Stemcr.2014.04.020 |
0.487 |
|
| 2014 |
Park H, Kim D, Kim CH, Mills RE, Chang MY, Iskow RC, Ko S, Moon JI, Choi HW, Man Yoo PS, Do JT, Han MJ, Lee EG, Jung JK, Zhang C, ... Lanza R, et al. Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategies. Stem Cells Translational Medicine. 3: 599-609. PMID 24763686 DOI: 10.5966/Sctm.2013-0149 |
0.35 |
|
| 2014 |
Chung YG, Eum JH, Lee JE, Shim SH, Sepilian V, Hong SW, Lee Y, Treff NR, Choi YH, Kimbrel EA, Dittman RE, Lanza R, Lee DR. Human somatic cell nuclear transfer using adult cells. Cell Stem Cell. 14: 777-80. PMID 24746675 DOI: 10.1016/J.Stem.2014.03.015 |
0.531 |
|
| 2014 |
Kimbrel EA, Kouris NA, Yavanian GJ, Chu J, Qin Y, Chan A, Singh RP, McCurdy D, Gordon L, Levinson RD, Lanza R. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells and Development. 23: 1611-24. PMID 24650034 DOI: 10.1089/Scd.2013.0554 |
0.561 |
|
| 2013 |
Lu SJ, Kelley T, Feng Q, Chen A, Reuveny S, Lanza R, Oh SK. 3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected]. Regenerative Medicine. 8: 413-24. PMID 23826696 DOI: 10.2217/Rme.13.36 |
0.58 |
|
| 2013 |
Pan CK, Heilweil G, Lanza R, Schwartz SD. Embryonic stem cells as a treatment for macular degeneration. Expert Opinion On Biological Therapy. 13: 1125-33. PMID 23705996 DOI: 10.1517/14712598.2013.793304 |
0.507 |
|
| 2013 |
Park KS, Cha Y, Kim CH, Ahn HJ, Kim D, Ko S, Kim KH, Chang MY, Ko JH, Noh YS, Han YM, Kim J, Song J, Kim JY, Tesar PJ, ... Lanza R, et al. Transcription elongation factor Tcea3 regulates the pluripotent differentiation potential of mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathway. Stem Cells (Dayton, Ohio). 31: 282-92. PMID 23169579 DOI: 10.1002/Stem.1284 |
0.472 |
|
| 2012 |
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (London, England). 379: 713-20. PMID 22281388 DOI: 10.1016/S0140-6736(12)60028-2 |
0.587 |
|
| 2012 |
Schwartz SD, Hubschman J, Heilwell G, Pan CK, Lanza R. Embryonic stem-cell-derived retinal pigment epithelial cells for macular degeneration – Authors' reply The Lancet. 379: 2050-2051. DOI: 10.1016/S0140-6736(12)60892-7 |
0.445 |
|
| 2011 |
Kimbrel EA, Lanza R. Stomping out barriers for hRBC mouse models. Blood. 118: 5719-20. PMID 22123907 DOI: 10.1182/Blood-2011-09-381152 |
0.328 |
|
| 2011 |
Rhee YH, Ko JY, Chang MY, Yi SH, Kim D, Kim CH, Shim JW, Jo AY, Kim BW, Lee H, Lee SH, Suh W, Park CH, Koh HC, Lee YS, ... Lanza R, et al. Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. The Journal of Clinical Investigation. 121: 2326-35. PMID 21576821 DOI: 10.1172/Jci45794 |
0.458 |
|
| 2011 |
Sugino IK, Sun Q, Wang J, Nunes CF, Cheewatrakoolpong N, Rapista A, Johnson AC, Malcuit C, Klimanskaya I, Lanza R, Zarbin MA. Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane. Investigative Ophthalmology & Visual Science. 52: 4979-97. PMID 21460262 DOI: 10.1167/Iovs.10-5386 |
0.51 |
|
| 2011 |
Lu SJ, Li F, Yin H, Feng Q, Kimbrel EA, Hahm E, Thon JN, Wang W, Italiano JE, Cho J, Lanza R. Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Research. 21: 530-45. PMID 21221130 DOI: 10.1038/Cr.2011.8 |
0.408 |
|
| 2010 |
Honig GR, Lu SJ, Feng Q, Vida LN, Lee BS, Lanza R. alpha-Thalassemia-like globin gene expression by primitive erythrocytes derived from human embryonic stem cells. Hemoglobin. 34: 145-50. PMID 20353349 DOI: 10.3109/03630261003676850 |
0.506 |
|
| 2010 |
Chang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. Plos One. 5: e9838. PMID 20352099 DOI: 10.1371/Journal.Pone.0009838 |
0.474 |
|
| 2010 |
Lu SJ, Feng Q, Park JS, Lanza R. Directed differentiation of red blood cells from human embryonic stem cells. Methods in Molecular Biology (Clifton, N.J.). 636: 105-21. PMID 20336519 DOI: 10.1007/978-1-60761-691-7_7 |
0.588 |
|
| 2010 |
Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, Kim KS, Lanza R. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells (Dayton, Ohio). 28: 704-12. PMID 20155819 DOI: 10.1002/Stem.321 |
0.597 |
|
| 2009 |
Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells (Dayton, Ohio). 27: 2126-35. PMID 19521979 DOI: 10.1002/Stem.149 |
0.406 |
|
| 2009 |
Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 4: 472-6. PMID 19481515 DOI: 10.1016/J.Stem.2009.05.005 |
0.423 |
|
| 2009 |
Maisano X, Carpentino J, Becker S, Lanza R, Aaron G, Grabel L, Naegele JR. Embryonic stem cell-derived neural precursor grafts for treatment of temporal lobe epilepsy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 263-77. PMID 19332319 DOI: 10.1016/J.Nurt.2009.01.011 |
0.419 |
|
| 2009 |
Wilcox JT, Semple E, Gartley C, Brisson BA, Perrault SD, Villagómez DA, Tayade C, Becker S, Lanza R, Betts DH. Characterization of canine embryonic stem cell lines derived from different niche microenvironments. Stem Cells and Development. 18: 1167-78. PMID 19327015 DOI: 10.1089/Scd.2008.0336 |
0.547 |
|
| 2009 |
Chung Y, Bishop CE, Treff NR, Walker SJ, Sandler VM, Becker S, Klimanskaya I, Wun WS, Dunn R, Hall RM, Su J, Lu SJ, Maserati M, Choi YH, Scott R, ... ... Lanza R, et al. Reprogramming of human somatic cells using human and animal oocytes. Cloning and Stem Cells. 11: 213-23. PMID 19186982 DOI: 10.1089/Clo.2009.0004 |
0.407 |
|
| 2009 |
Lu SJ, Ivanova Y, Feng Q, Luo C, Lanza R. Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells. Regenerative Medicine. 4: 37-47. PMID 19105615 DOI: 10.2217/17460751.4.1.37 |
0.545 |
|
| 2009 |
Li F, Lu S, Feng Q, Lanza R. Large Scale Generation of Functional Megakaryocytes From Human Embryonic Stem Cells (hESCs) Under Stromal-Free Conditions. Blood. 114: 2540-2540. DOI: 10.1182/Blood.V114.22.2540.2540 |
0.577 |
|
| 2009 |
Kimbrel EA, Lu S, Lanza R. Generation of Functional Lymphoid (Natural Killer) Cells From Human ESC-Derived Hemangioblasts. Blood. 114: 1502-1502. DOI: 10.1182/Blood.V114.22.1502.1502 |
0.555 |
|
| 2008 |
Lu SJ, Luo C, Holton K, Feng Q, Ivanova Y, Lanza R. Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regenerative Medicine. 3: 693-704. PMID 18729794 DOI: 10.2217/17460751.3.5.693 |
0.587 |
|
| 2008 |
Lu SJ, Feng Q, Park JS, Vida L, Lee BS, Strausbauch M, Wettstein PJ, Honig GR, Lanza R. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 112: 4475-84. PMID 18713948 DOI: 10.1182/Blood-2008-05-157198 |
0.535 |
|
| 2008 |
Chung Y, Klimanskaya I, Becker S, Li T, Maserati M, Lu S, Zdravkovic T, Ilic D, Genbacev O, Fisher S, Krtolica A, Lanza R. Human Embryonic Stem Cell Lines Generated without Embryo Destruction Cell Stem Cell. 2: 113-117. PMID 18371431 DOI: 10.1016/J.Stem.2007.12.013 |
0.469 |
|
| 2008 |
Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells (Dayton, Ohio). 26: 1117-27. PMID 18292207 DOI: 10.1634/stemcells.2007-1102 |
0.379 |
|
| 2008 |
Klimanskaya I, Rosenthal N, Lanza R. Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nature Reviews. Drug Discovery. 7: 131-42. PMID 18079756 DOI: 10.1038/Nrd2403 |
0.573 |
|
| 2007 |
Lanza R. Stem cell breakthrough: don't forget ethics. Science. 318: 1865-1865. PMID 18096789 DOI: 10.1126/Science.318.5858.1865A |
0.478 |
|
| 2007 |
Lu SJ, Hipp JA, Feng Q, Hipp JD, Lanza R, Atala A. GeneChip analysis of human embryonic stem cell differentiation into hemangioblasts: an in silico dissection of mixed phenotypes. Genome Biology. 8: R240. PMID 17999768 DOI: 10.1186/Gb-2007-8-11-R240 |
0.555 |
|
| 2007 |
Lu SJ, Feng Q, Ivanova Y, Luo C, Li T, Li F, Honig GR, Lanza R. Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells. Stem Cells and Development. 16: 547-59. PMID 17784829 DOI: 10.1089/Scd.2007.0002 |
0.562 |
|
| 2007 |
Klimanskaya I, Chung Y, Becker S, Lu S, Lanza R. Derivation of human embryonic stem cells from single blastomeres Nature Protocols. 2: 1963-1972. PMID 17703208 DOI: 10.1038/Nprot.2007.274 |
0.553 |
|
| 2007 |
Lu SJ, Feng Q, Caballero S, Chen Y, Moore MA, Grant MB, Lanza R. Generation of functional hemangioblasts from human embryonic stem cells. Nature Methods. 4: 501-9. PMID 17486087 DOI: 10.1038/Nmeth1041 |
0.547 |
|
| 2007 |
Lanza R. After DollyThe uses and misuses of human cloning Journal of Clinical Investigation. 117: 283-283. DOI: 10.1172/Jci31305 |
0.493 |
|
| 2007 |
Klimanskaya I, Chung Y, Becker S, Lu S, Lanza R. Human embryonic stem cell lines derived from single blastomeres Obstetrical & Gynecological Survey. 62: 31-32. DOI: 10.1097/01.Ogx.0000251105.01117.45 |
0.567 |
|
| 2007 |
Klimanskaya I, Chung Y, Becker S, Lu S, Lanza R. Erratum: Human embryonic stem cell lines derived from single blastomeres Nature. 446: 342-342. DOI: 10.1038/Nature05608 |
0.496 |
|
| 2006 |
Lund RD, Wang S, Klimanskaya I, Holmes T, Ramos-Kelsey R, Lu B, Girman S, Bischoff N, Sauvé Y, Lanza R. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning and Stem Cells. 8: 189-99. PMID 17009895 DOI: 10.1089/Clo.2006.8.189 |
0.494 |
|
| 2006 |
Klimanskaya I, Chung Y, Becker S, Lu S, Lanza R. Human embryonic stem cell lines derived from single blastomeres Nature. 444: 481-485. PMID 16929302 DOI: 10.1038/Nature05142 |
0.601 |
|
| 2006 |
Chung Y, Klimanskaya I, Becker S, Marh J, Lu S, Johnson J, Meisner L, Lanza R. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres Nature. 439: 216-219. PMID 16227970 DOI: 10.1038/Nature04277 |
0.551 |
|
| 2006 |
Koh CJ, Yoo JJ, Lee J, Chen K, Söker S, Lanza R, Atala A. 603: In Vivo Engineering of Tissues Using Parthenogenesis-Derived Stem Cells for Urologic Reconstruction Journal of Urology. 175: 195-195. DOI: 10.1016/S0022-5347(18)32849-0 |
0.449 |
|
| 2005 |
Lanza R, Green RM. Bush's policy stopped US gaining stem-cell lead. Nature. 438: 422. PMID 16306965 DOI: 10.1038/438422A |
0.46 |
|
| 2005 |
Lanza R, Shieh J-, Wettstein PJ, Sweeney RW, Wu K, Weisz A, Borson N, Henderson B, West MD, Moore MAS. Long-term bovine hematopoietic engraftment with clone-derived stem cells. Cloning and Stem Cells. 7: 95-106. PMID 15971983 DOI: 10.1089/Clo.2005.7.95 |
0.481 |
|
| 2005 |
Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R. Human embryonic stem cells derived without feeder cells. The Lancet. 365: 1636-1641. PMID 15885296 DOI: 10.1016/S0140-6736(05)66473-2 |
0.591 |
|
| 2004 |
Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, Lanza R. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning and Stem Cells. 6: 217-245. PMID 15671670 DOI: 10.1089/Clo.2004.6.217 |
0.571 |
|
| 2004 |
Lanza R, Rosenthal N. The Stem Cell Challenge Scientific American. 290: 92-99. PMID 15195398 DOI: 10.1038/Scientificamerican0604-92 |
0.562 |
|
| 2004 |
Lanza R, Moore MA, Wakayama T, Perry AC, Shieh JH, Hendrikx J, Leri A, Chimenti S, Monsen A, Nurzynska D, West MD, Kajstura J, Anversa P. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circulation Research. 94: 820-7. PMID 14764454 DOI: 10.1161/01.Res.0000120863.53562.Df |
0.485 |
|
| 2004 |
Koh C, Lanza R, Soker S, Yoo J, Atala A. Parthenogenesis: A novel source of stem cells for reconstruction Journal of the American College of Surgeons. 199: 101-102. DOI: 10.1016/J.Jamcollsurg.2004.05.229 |
0.587 |
|
| 1979 |
West CM, Lanza R, Rosenbloom J, Lowe M, Holtzer H, Avdalovic N. Fibronectin alters the phenotypic properties of cultured chick embryo chondroblasts. Cell. 17: 491-501. PMID 476827 DOI: 10.1016/0092-8674(79)90257-5 |
0.353 |
|
| 1977 |
Ali IU, Mautner V, Lanza R, Hynes RO. Restoration of normal morphology, adhesion and cytoskeleton in transformed cells by addition of a transformation-sensitive surface protein. Cell. 11: 115-26. PMID 326414 DOI: 10.1016/0092-8674(77)90322-1 |
0.354 |
|
| Show low-probability matches. |